Latest Breaking News On - Jianyong li - Page 1 : comparemela.com

Live from ASH 2023 | Ascentage Pharma Releases Encouraging Long-Term Data of Bcl-2 Inhibitor Lisaftoclax in R/R CLL, Including an ORR of 73 3%

/PRNewswire/ Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and.

Hong kongUnited statesSan diegoAscentage pharmaJianyong liPrnewswire ascentage pharmaKeshu zhouYifan zhaiAmerican society of hematologyMajor nationalMd anderson cancer centerChina national medical products administrationNational reimbursement drug listDana farber cancer institutePoster presentationAmerican society

ASH 2023 | Ascentage Pharma to Present Results from Three Clinical Studies of Bcl-2 Inhibitor Lisaftoclax (APG-2575), Including the First Data in AML and MM

ASH 2023 | Ascentage Pharma to Present Results from Three Clinical Studies of Bcl-2 Inhibitor Lisaftoclax (APG-2575), Including the First Data in AML and MM
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesHong kongQian jiangJianyong liJianxiang wangPrnewswire ascentage pharmaHuafeng wangElias jabbourXiaojun huangJie jinKeshu zhouSikander ailawadhiXiaoyuan gongYifan zhaiLiposome mitoxantrone

ASH 2023 | For the Sixth Consecutive Year, Results from Multiple Clinical Studies of Olverembatinib Have Been Selected for Presentations, Including Two Oral Reports, at the 2023 ASH Annual Meeting

ASH 2023 | For the Sixth Consecutive Year, Results from Multiple Clinical Studies of Olverembatinib Have Been Selected for Presentations, Including Two Oral Reports, at the 2023 ASH Annual Meeting
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesUnited kingdomQian jiangHong kongHagop kantarjianJianyong liPrnewswire ascentage pharmaYifan zhaiJianxiang wangAscentage pharmaLiposome mitoxantroneInnovent biologicsSikander ailawadhiHuafeng wangHongsheng zhou

ENTREPRENEUR UNIVERSE BRIGHT GROUP Announces 2023 Q2 Financial Results

/PRNewswire/ ENTREPRENEUR UNIVERSE BRIGHT GROUP ("EUBG" or the "Company") (OTCQB: EUBG), a digital marketing consulting company, announced its unaudited.

Hong kongJianyong liTina liGuolin taoEntrepreneur universe bright groupEvergreen consulting incCondensed consolidated statementThree months ended juneMonths ended juneEnterprise income taxSix months ended junePrivate securities litigation reform act

ENTREPRENEUR UNIVERSE BRIGHT GROUP Announces 2023 Q2 Financial Results

ENTREPRENEUR UNIVERSE BRIGHT GROUP Announces 2023 Q2 Financial Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Hong kongJianyong liTina liGuolin taoEvergreen consulting incEntrepreneur universe bright groupCondensed consolidated statementThree months endedEnterprise income taxSix months endedPrivate securities litigation reform act